Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Insomnic ischemic stroke patients with OSA and depression.~Exclusion Criteria:~* unclear consciousness, unstable vital sign or neurologic sign, unstable medical conditions such as delirium, active infection, evidence of overt congestive cardiac failure, liver dysfunction with ascites, thyroid disease, end-stage-renal-disease receiving dialysis.~* overnight mean oxygen saturation (SaO2) nadir is ≤ 70% at baseline~* take monoamine oxidase inhibitors (MAOI), any medication that may affect breathing, sleep, or muscle activity~* any known allergy to trazodone~* sleep disorder other than OSA (e.g., periodic leg movement syndrome, restless legs syndrome, central sleep apnea/Cheyne-Stokes respiration).

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Trazodone (Type: ACTIVE_COMPARATOR): take trazodone 100mg hs
- Placebo (Type: PLACEBO_COMPARATOR): take placebo pill hs

Based on this trial design, predict the completion outcome and termination type (if applicable).